The third era of genomics is at risk of being dismantled across the global south
Science · 2024
DOI: 10.1126/science.adt4843 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2024. Verfasst von Tulio de Oliveira. Beteiligte Einrichtung: Centre for Epidemic Response and Innovation (CERI), Stellenbosch University, Stellenbosch, South Africa. tulio@sun.ac.za. Hauptthemen laut MEDLINE: Genomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
The first era of genomics started with the publication of Watson and Crick’s notable work on the description of the DNA double helix in 1953. This era lasted 50 years, until the publication of the human genome in April 2003. The second era is associated with the period between the completion of the human genome and the present day. I argue that, with the discontinuity caused by the COVID-19 pandemic and the spread and increased use of genomics to every corner of the world, we are entering a new, third era of genomics that provides major opportunities to advance the health of humans, animals, and the planet. However, this can only happen if the capacity that has greatly expanded in recent years is maintained and expanded further rather than left to atrophy, particularly across the global south.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for Epidemic Response and Innovation (CERI), Stellenbosch University, Stellenbosch, South Africa. tulio@sun.ac.za.
ORCID-Profile: Tulio de Oliveira
Zitieren
APA
de Oliveira, T. (2024). The third era of genomics is at risk of being dismantled across the global south. Science. https://doi.org/10.1126/science.adt4843
Vancouver
de Oliveira T. The third era of genomics is at risk of being dismantled across the global south. Science. 2024. doi:10.1126/science.adt4843
BibTeX
@article{deOliveira2024,
author = {de Oliveira, Tulio},
title = {The third era of genomics is at risk of being dismantled across the global south},
journal = {Science},
year = {2024},
doi = {10.1126/science.adt4843}
}
EUVIMED